40 Top-Tier Companies Selected to Debut at the RESI Innovation Challenge

31 Aug

By Christine A. Wu, Senior Research Analyst, LSN

chrsitineWe are pleased to announce our forty finalists to compete in the Innovation Challenge at LSN’s 2017 RESI in Boston on September 26th. From a pool of over 100 applicants, the LSN Scientific Review Committee has selected a mixture of healthcare IT, diagnostic, therapeutic, and medical device companies, a portion of which have received funding from NIH or partnered with Techstars-Cedars Sinai. The quality of these companies should not go unnoticed, as we have seen nearly 50% of Innovation Challenge finalists from previous RESI events receive funding within one year of their debut.

From a CAR-T therapy for solid tumors to a patient management telehealth platform for chronic diseases, these companies cover a diverse range of life science technologies. Coming from all over the world, the companies will be competing based on scientific merit and investment potential, pitching to RESI attendees and showcasing their innovations. Be sure to meet them and make your “investments” at the RESI Exhibition Hall on September 26th!

Diagnostic

Therapeutic

Medical Device

Healthcare IT

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s

%d bloggers like this: